You Searched For "biocon s kiran majumdar shaw" and got 20 results
Sort By:
1 min read
Highly skilled recruitment must be exempted from job quota bill for Karnataka's own sake: Biocon Chairperson
According to Biocon Ltd Chairperson Kiran Mazumdar-Shaw, the job reservation for locals must not af…
PTI
2 mins read
Zerodha founder Nithin Kamath recovering from stroke he underwent 6 weeks ago
Founder and CEO of stock broker Zerodha, Nithin Kamath, had a "mild stroke" about six weeks ago and…
ANI
2 mins read
Serum Institute of Life Sciences to invest additional $150 million in Biocon arm
The Serum Institute of Life Sciences said on Tuesday that it will invest another $150 million in Bi…
1 min read
Biocon raises ₹1,070 crore from Kotak Special Situations Fund
Biocon Biologics completed the acquisition of Viatris’ global biosimilars business in November 2022…
1 min read
Biocon Q1FY23 revenue up 23% at Rs 2,217 cr
Global biopharmaceuticals company Biocon on Wednesday reported 23 per cent rise in revenue for the …
1 min read
Kiran Mazumdar-Shaw to retire from Infosys board
Kiran Mazumdar-Shaw was appointed to the Infosys' Board as an Independent Director in 2014, and as …
ANI
1 min read
Finance Minister Nirmala Sitharaman holds the first round of pre-budget talks with top industrialists
New Delhi, Dec.With the union budget-making process getting underway, Finance Minister Nirmala Sith…
2 mins read
Catch Kiran Mazumdar Shaw at the Global Trends Festival 2020, speak about unlocking India's suppressed potential
Kiran Mazumdar Shaw is India's richest self-made woman. She started Biocon at the age of 25 and h…
3 mins read
₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500— here’s why
Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…
3 mins read
Biocon’s Kiran Mazumdar Shaw, who debuted in the pharma industry with two employees and $500 becomes EY World Entrepreneur of the Year 2020
With this, she has joined the likes of Uday Kotak of Kotak Mahindra Bank and Narayana Murthy of …
2 mins read
Biocon’s subsidiary raises $30 million from Tata Capital – company’s shares jump by almost 2%
Biocon’s subsidiary company Biocon Biologics has raised $30 million from Tata Capital Growth Fund, …
2 mins read
Nykaa’s Falguni Nayar overtakes Kiran Mazumdar Shaw as the richest self-made Indian woman
Falguni Nayar is the richest self-made billionaire with a net worth of ₹57,520 crore.However, Roshn…
3 mins read
Biocon was a hot stock before the latest earnings— from Tata Asset Management to Baroda AMC, at least five mutual fund houses added it to their portfolio
The biopharma major with a market value of over $5 billion blamed the COVID-19 crisis for the fa…
1 min read
Biocon executive chairperson Kiran Mazumdar-Shaw says she has COVID-19
Bengaluru, Aug 17 () Executive chairperson of Bengaluru-headquartered Biocon Ltd Kiran Mazumdar-Sha…
PTI
3 mins read
Biocon shares are depressed itself but Syngene can offer a shot of hope
The Bengaluru-based biopharmaceutical company Biocon Limited share price fell over 3%. Investors …
3 mins read
There are a lot of coronavirus vaccines in the works— but these are the two that Indians should watch out for
“I think the Oxford vaccine and Chinese vaccine are certainly in the more advanced clinical phas…
2 mins read
Don’t hold your breath — Biocon founder Kiran Mazumdar Shaw says India's Covid-19 vaccine will enter clinical trials in 9 months
There are at least six vaccines under development in India, of the total 100 around the world inclu…
1 min read
Billionaire Kiran Mazumdar Shaw says she is willing to provide free testing for coronavirus
During a conference call with the media for the launch of Apollo’s Project Stay I – an initiativ…
2 mins read
Kiran Mazumdar Shaw wanted to be a brewmaster before building the largest biotech company in India
Kiran Mazumdar Shaw is India’s richest self-made woman in India with a net worth of $3.2 billion. B…
4 mins read
Narendra Modi has a new problem – big corporates and moneybags are angry
Even Mohandas Pai, the former Infosys director who is currently a private investor who backs s…